ATI
LLY icon

Act Two Investors’s Eli Lilly LLY Stock Holding History

Act Two Investors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.2M Buy
19,302
+11,128
+136% +$11.4M 4.68% 7
2026
Q1 		$7.52M Sell
8,174
-266
-3% -$270K 1.66% 17
2025
Q4 		$9.07M Sell
8,440
-9
-0.1% -$8.61K 1.63% 17
2025
Q3 		$6.45M Buy
+8,449
New +$6.29M 1.14% 20

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Act Two Investors's LLY Position: Q2 2026 in Review

Act Two Investors increased its Eli Lilly (LLY) stake by 136% in Q2 2026, buying an estimated $11.4M and bringing the position to 19,302 shares worth $23.2M. The position accounts for 4.68% of the portfolio, ranked #7.

Act Two Investors first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Act Two Investors held 19,302 shares of Eli Lilly worth $23.2M as of Q2 2026.
  • Act Two Investors bought 11,128 Eli Lilly shares in Q2 2026, an estimated $11.4M.
  • Eli Lilly made up 4.68% of Act Two Investors's portfolio in Q2 2026, its #7 holding.
  • Act Two Investors first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Act Two Investors's 13F filing for Q2 2026, filed 10 Aug 2026.